Navigation Links
Sun Yat-sen University and Johns Hopkins sign collaboration agreement
Date:3/4/2013

The training of next-generation clinical investigators in China is at the core of a new collaboration between Sun Yat-sen University (SYSU) and its affiliated hospitals in Guangzhou, China, and The Johns Hopkins University and Johns Hopkins Medicine International in Baltimore, USA.

The agreement between the academic medical centers was signed today in Guangzhou. It will provide a long-term platform for exchanges among clinical and translational investigators, research professionals and administrators in both countries, and will lay the foundation for building world-class research infrastructure in China, according to representatives of both institutions.

"China's health care sector and biomedical research field are growing rapidly," says Daniel Ford, M.D., M.P.H., professor and vice dean of clinical investigation at the Johns Hopkins University School of Medicine. "We are honored to have this opportunity to collaborate with SYSU and its affiliated hospitals to improve research processes, infrastructure and systems. We see this endeavor as a natural extension of Johns Hopkins Medicine's global mission and vision."

"We look forward to working with our colleagues at Johns Hopkins in the areas of clinical and translational research," says Ningsheng Xu, Ph.D., president of SYSU. "We firmly believe that this endeavor will become a milestone in the globalization of our university. The sharing of knowledge between our two institutions will help advance medical science and health care delivery in China, the United States and beyond."

In the first phase of the collaboration, Johns Hopkins experts will travel to SYSU to teach courses and lead workshops designed to strengthen development of investigators and research professionals. These experts also will design a competitive fellowship program at Johns Hopkins for promising SYSU investigators and junior faculty members, and provide strategic and technical advice on a wide range of issues that include research infrastructure, operations, safety and governance.

The agreement will also provide seed grants for collaborative clinical and translational pilot projects that have the potential to develop into larger studies funded by industry or government sources in China and the United States.

"This collaboration demonstrates our commitment to becoming a regional leader in clinical and translational research," says Mengfeng Li, Ph.D., vice president of SYSU and dean of SYSU's Zhongshan School of Medicine. "It is an opportunity for us to leverage Johns Hopkins' expertise in the discovery and application of the latest research advances. We are confident that the sooner we can enhance our training programs and research infrastructure, the sooner we can foster the kind of international collaborative research that will make a difference in people's lives in China and throughout the world."


'/>"/>

Contact: Natalia Abel
nboloti1@jhmi.edu
410-464-6645
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Members of University Services Sleep Diagnostic & Treatment Centers Wake Up Industries and Communities to the Importance of Sleep for Sleep Awareness Week
2. Book by University of Oregon psychologists opens eyes on betrayal
3. Case Western Reserve University joins BrainGate clinical trial
4. Baylor University researchers study barriers, resources to physical activity in Texas towns
5. Animal Cell Therapies, Inc. and University of Florida Receive $330k Grant from The Sabes Foundation for Stem Cell Study
6. Rice University analysis links ozone levels, cardiac arrest
7. NIKE Softball Camps Announces New Northeast Location at Bryant University
8. Quality Communication Solutions to Participate in Career Fair at Drake University in Des Moines, Iowa on February 14, 2013
9. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
10. University of Minnesota researchers discover enzyme behind breast cancer mutations
11. University of California Irvine, Medical Center Selects Jvion as their ICD-10 Risk Assessment and Crosswalk Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology: